Correlation Between Johnson Johnson and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Carmell Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Carmell Therapeutics.
Diversification Opportunities for Johnson Johnson and Carmell Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Carmell is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Johnson Johnson and Carmell Therapeutics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 24.0 times less return on investment than Carmell Therapeutics. But when comparing it to its historical volatility, Johnson Johnson is 19.78 times less risky than Carmell Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Carmell Therapeutics on September 2, 2024 and sell it today you would lose (9.00) from holding Carmell Therapeutics or give up 60.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 31.45% |
| Values | Daily Returns |
Johnson Johnson vs. Carmell Therapeutics
Performance |
| Timeline |
| Johnson Johnson |
| Carmell Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Insignificant
Johnson Johnson and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Carmell Therapeutics
The main advantage of trading using opposite Johnson Johnson and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Johnson Johnson vs. Crinetics Pharmaceuticals | Johnson Johnson vs. Enanta Pharmaceuticals | Johnson Johnson vs. Amicus Therapeutics | Johnson Johnson vs. Connect Biopharma Holdings |
| Carmell Therapeutics vs. Sonida Senior Living | Carmell Therapeutics vs. Akanda Corp | Carmell Therapeutics vs. IPG Photonics | Carmell Therapeutics vs. NextNav Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stocks Directory Find actively traded stocks across global markets |